Antibiotic-selective environments

Clinical Infectious Diseases

Volumn 27, Issue SUPPL.1, 1998, Pages

  Baquero, Fernando ^a,b   Negri, Maria Cristina ^a   Morosini, Maria Isabel ^a   Blázquez, Jesús ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIUM; CONFERENCE PAPER; DRUG USE; EVOLUTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031879280     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514916     Document Type: Conference Paper

References (28)

1. Brandon RN. Environment. In: Keller EF, Lloyd EA, eds. Key words in evolutionary biology. Cambridge, Massachusetts: Harvard University Press, 1992:81-6.
2. Asensio A, Guerrero A, Quereda C, Lizan M, Martínez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996; 17:20-8.
3. Aguiar JM, Chacon J, Cantón R, Baquero F. The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother 1992;29:349-50.
4. Baquero F, Martínez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28 (suppl C):31-8.
5. Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J Antimicrob Chemother 1996;38 (suppl A):117-32.
6. Baquero F, the Task Force of the General Direction for Health Planning of the Spanish Ministry of Health. Antibiotic resistance in Spain: what to be done? Clin Infect Dis 1996;23:819-23.
7. Tenover FC, McGowan JE. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996;311:9-16.
8. Davies J. Another look at antibiotic resistance. J Gen Microbiol 1992; 138:1553-9.
9. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
10. Blázquez J, Morosini MI, Negri MC, González-Leiza M, Baquero F. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. Antimicrob Agents Chemother 1995;39:145-9.
11. Baquero F, Negri MC, Morosini MI, Blázquez J. The antibiotic selective process: concentration-specific amplification of low-level resistant populations. In: Chadwick DJ, Goode J, eds. Antibiotic resistance: origins, evolution and spread. New York: John Wiley and Sons, 1997:93-111.
12. Levin BR. Frequency-dependent selection in bacterial populations. In: Clarke BC, Partridge L, eds. Frequency-dependent selection. London: The Royal Society, 1988:1-14.
13. Negri MC, Morosini MI, Loza E, Baquero F. In vitro selective concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother 1994;38:122-5.
14. Baquero F, Negri MC. Selective compartments for resistant microorganisms in antibiotic gradients. BioEssays 1997;19:731-6.
15. Blázquez J, Negri MC, Morosini MI, Gómez-Gómez JM, Baquero F, Valencia A. The role of Thr237 mutation in shifting TEM-10 into TEM-5: a neutral mutation equilibrating the beta-lactamase substrate preference [abstract C77]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1996:77.
16. Thorisdottir RA, Bonomo DM, Shlaes DM, Rice LB. Klebsiella pneumoniae strains resistant to both ceftazidime and ampicillin/sulbactam [abstract C76]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). Washington, DC: American Society for Microbiology, 1994:90.
17. Sirot D, Recule C, Chaibi EB, et al. A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob Agents Chemother 1997;41:1322-5.
18. Chen HY, Yuan M, Ibrahim-Elmagboal IB, Livermore DM. National survey of susceptibility to antimicrobials among clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 1995;35:521-34.
19. Yoneyama H, Yamano Y, Wakae T. Role of porins in the antibiotic susceptibility of Pseudomonas aeruginosa: construction of mutants with deletions in the multiple porine genes. Biochem Biophys Res Commun 1995;213:88-95.
20. Sumita Y, Fukasawa M. Meropenem resistance in Pseudomonas aeruginosa. Chemotherapy 1996;42:47-56.
21. Li X, Nikaido H, Poole K. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995;34: 281-6.
22. Köhler T, Michéa-Hamzehpour M, Henze U, Gotoh N, Kocjancic-Curty L, Pechère JC. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997;23:345-54.
23. Toltzis P. Antibiotic-resistant gram-negative bacteria in the critical care setting. Ped Clin North Am 1995;42:687-702.
24. Sober E. The nature of selection. Chicago: The University of Chicago Press, 1984:87-102.
25. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Genes acrA and acrB encode a stress-induced efflux system in Escherichia coli. Mol Microbiol 1995;16:45-55.
26. Foster P. Adaptive mutation. In: Baumberg S, Young JPW, Wellington EMH, Saunders JR, eds. Population genetics of bacteria. Cambridge: Cambridge University Press, 1995:13-30.
27. + mutants of Escherichia coli MCS2. J Bacteriol 1997;179:4620-2.
28. Taddei F, Radman M, Maynard-Smith J, Toupance B, Gouyon PH, Godelle B. Role of mutator alleles in adaptive evolution. Nature 1997;387: 700-2.